<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">6255061</article-id><article-id pub-id-type="doi">10.1093/ofid/ofy210.458</article-id><article-id pub-id-type="publisher-id">ofy210.458</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>B. Poster Abstracts</subject></subj-group></subj-group></article-categories><title-group><article-title>449. Post-Hurricane Maria Surveillance for Infectious Diseases in the Veterans Affairs San Juan Medical Center, Puerto Rico</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Oda</surname><given-names>Gina</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Matanock</surname><given-names>Almea</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Hunter</surname><given-names>Jennifer C</given-names></name><degrees>MPH, DrPH</degrees><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Anita</given-names></name><degrees>PharmD, MS</degrees><xref ref-type="aff" rid="AF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Pillai</surname><given-names>Satish</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="AF0005">5</xref></contrib><contrib contrib-type="author"><name><surname>Styles</surname><given-names>Timothy</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="AF0006">6</xref></contrib><contrib contrib-type="author"><name><surname>Saavedra</surname><given-names>Sonia</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0007">7</xref></contrib><contrib contrib-type="author"><name><surname>Martinez</surname><given-names>Mirsonia</given-names></name><degrees>CIC</degrees><xref ref-type="aff" rid="AF0007">7</xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Makoto</given-names></name><degrees>MD, MS</degrees><xref ref-type="aff" rid="AF0008">8</xref></contrib><contrib contrib-type="author"><name><surname>Mecher</surname><given-names>Carter</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0009">9</xref></contrib><contrib contrib-type="author"><name><surname>Ryono</surname><given-names>Russell</given-names></name><degrees>Pharm. D</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Holodniy</surname><given-names>Mark</given-names></name><degrees>MD, FIDSA, FSHEA</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Public Health Surveillance and Research, Department of Veterans Affairs, Palo Alto, California</aff><aff id="AF0002"><label>2</label>Waterborne Disease Prevention Branch, Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0003"><label>3</label>Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Foodborne, Waterborne, and Environmental Diseases, Atlanta, Georgia</aff><aff id="AF0004"><label>4</label>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0005"><label>5</label>Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0006"><label>6</label>Hurricane Response, Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0007"><label>7</label>VA Caribbean Healthcare System, San Juan, PR</aff><aff id="AF0008"><label>8</label>Internal Medicine, VA Salt Lake City Health Care System, Salt Lake City, Utah</aff><aff id="AF0009"><label>9</label>Patient Care Services, Department of Veterans Affairs, Washington, DC</aff><pub-date pub-type="collection"><month>11</month><year>2018</year></pub-date><pub-date pub-type="epub" iso-8601-date="2018-11-26"><day>26</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>11</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>5</volume><issue>Suppl 1</issue><issue-title>ID Week 2018 Abstracts</issue-title><fpage>S168</fpage><lpage>S169</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2018</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="ofy210.458.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>On September 20, 2017 Category 4 Hurricane Maria made landfall in Puerto Rico (PR), causing widespread flooding, power outages, and lack of water service. Given the potential for infectious disease outbreaks, the Department of Veterans Affairs (VA) and Centers for Disease Control and Prevention established enhanced surveillance to actively monitor priority infections at VA facilities.</p></sec><sec id="s2"><title>Methods</title><p>We queried VA data sources from August 27, 2017 to February 3, 2018 (pre-storm dates included to establish baselines). Trends in infectious disease ICD-10 syndrome groupings (respiratory illness/pneumonia, Influenza-like illness (ILI), gastrointestinal illness, conjunctivitis, rash-like Illness, jaundice) as a percent of total emergency department (ED) visits were tracked. The total number of laboratory tests performed, and percent positive per week, for influenza, hepatitis A, dengue (DENV), zika (ZIKV), leptospirosis, and chikungunya (CHIKV) were calculated.</p></sec><sec id="s3"><title>Results</title><p>ILI increased from 9.3% to 12.6% during the surveillance period (peak epi week 52: 15.7%) (Figure 1), while other ICD-10&#x02013;based syndromes remained relatively stable. Weekly influenza testing increased shortly after landfall averaging 105 rapid influenza tests per week (epi weeks 41&#x02013;4) (Figure 2). Influenza positivity increased in epi weeks 41 and 42 (7%), dropping the following weeks, and peaked at 15% in epi week 2 (Figure 3). Four acute infections were detected: 2 + leptospirosis DNA, 1 + CHIKV RNA, and 1 + Hepatitis A IgM. The remaining 34 positive tests were ZIKV, CHIKV, or DENV IgM positive or equivocal, awaiting confirmation (Figure 3).</p></sec><sec id="s4"><title>Conclusion</title><p>We quickly established a simple surveillance system to monitor trends in priority infectious diseases. Increases in ILI, weekly influenza testing volume, and percent positive of influenza tests coincided with onset of influenza season. Diseases of public health importance were identified through laboratory-based surveillance. The impact of Maria on VA healthcare operations, including clinic closures, power outages, and disrupted care seeking patterns limited this system. However, the timeliness and flexibility of this surveillance system provides a model for disease monitoring following future natural disasters.</p><fig id="F1" orientation="portrait" position="float"><caption><p>Figure 1.</p></caption><graphic xlink:href="ofidis_ofy210_f0144"/></fig><fig id="F2" orientation="portrait" position="float"><caption><p>Figure 2.</p></caption><graphic xlink:href="ofidis_ofy210_f0145"/></fig><fig id="F3" orientation="portrait" position="float"><caption><p>Figure 3.</p></caption><graphic xlink:href="ofidis_ofy210_f0146"/></fig></sec><sec id="s5"><title>Disclosures</title><p>
<bold>All authors:</bold> No reported disclosures.</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front><back><notes id="n1"><p>
<bold>Session:</bold> 57. Global Health and Travel Medicine</p><p>
<italic>Thursday, October 4, 2018: 12:30 PM</italic>
</p></notes></back></article>